Evidence map›Paper›PMID 39345954›Full record

ArticleBiomedical reports2024

Nephrotic syndrome as a possible indicator of colonic cancer: A case report.

Roxana Surugiu, Ștefănița Bianca Vintilescu, Raluca Elena Sandu, Denisa Pirscoveanu, Daniel Pirici, Carmen Daniela Neagoe, Daniela Matei, Mădălina Aldea, Gheorghe Gindrovel Dumitra, Mioara Desdemona Stepan and 1 more

Abstract readCase Reports
In one paragraph

Article in Biomedical reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roxana SurugiuDepartment of Biochemistry, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Ștefănița Bianca VintilescuDepartment of Infant Care-Pediatrics-Neonatology, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Raluca Elena SanduDepartment of Biochemistry, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Denisa PirscoveanuDepartment of Neurology, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Daniel PiriciDepartment of Pathology, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Carmen Daniela NeagoeDepartment of Internal Medicine, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Daniela MateiDepartment of Physical Medicine and Rehabilitation, University of Medicine and Pharmacy of Craiova, Craiova 200433, Romania.
Mădălina AldeaDepartment of Psychiatry, University of Medicine and Pharmacy of Craiova, Craiova 200433, Romania.
Gheorghe Gindrovel DumitraDepartment of Family Medicine, University of Medicine and Pharmacy of Craiova, Craiova 200349, Romania.
Mioara Desdemona StepanDepartment of Infant Care-Pediatrics-Neonatology, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.
Amelia Valentina Genunche-DumitrescuDepartment of Internal Medicine, University of Medicine and Pharmacy of Craiova, St. Petru Rares, Craiova 200433, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of paraneoplastic syndromes encompasses a spectrum of indirect clinical manifestations caused by secretion of bioactive products by malignant cells. Paraneoplastic glomerulopathy represent a distinct clinical entity where nephrotic syndrome can arise as a manifestation of underlying malignancies, particularly solid tumors. Membranous nephropathy is notably associated with such malignancies, highlighting the intricate relationship between nephrotic syndrome and cancer. The present study reports the case of a 44-year-old Caucasian male, smoker (22 pack-years) and chronic ethanol consumer who presented in the Emergency County Hospital of Craiova in March 2018 with abdominal distension, genital and leg edema and no prior medical history. Laboratory tests revealed inflammatory syndrome (erythrocyte sedimentation rate=110 mm/h, fibrinogen, 150 mg/dl, high levels of C reactive protein=6.87 mg/dl), as well as hypoproteinemia (total protein levels=3.90 g/l), hypertriglyceridemia=213 mg/dl, hypercholesterolemia=475 mg/dl, total urinary protein excretion of 12,500 mg/24 h and normal levels of urea (38 mg/dl) and creatinine (0.90 mg/dl). After meeting the diagnostic criteria for nephrotic syndrome (edema, proteinuria, hypoalbuminemia, and hyperlipidemia, it was investigated whether the syndrome was primary or secondary in origin. Notably, an unexplained inflammatory syndrome in conjunction with elevated tumor marker levels (carbohydrate antigen 19-9, 82.47 U/ml; Carcinoembryonic antigen-CEA=9.46 ng/ml) prompted a thorough imagistic investigation, using computer tomography. A polyp was discovered during colonoscopy, prompting a biopsy. The presence of adenocarcinoma was confirmed by histopathological analysis. The only clinical manifestation of the colonic malignancy was the symptomatic presentation of nephrotic syndrome, which led to early detection of the underlying cancer. Paraneoplastic nephropathy connects kidney disease with systemic cancer, showing that renal symptoms may aid in diagnosing hidden malignancies. Nephrotic syndrome, especially membranous nephropathy, is associated with various solid tumors. The present case demonstrated that paraneoplastic syndrome, though rare, may lead to early cancer detection. Ongoing research is essential for improving understanding, targeted therapy and patient management.

Indexed as

colonic cancernephrotic syndromeparaneoplastic syndrome

Identifiers

PMID39345954
PMCPMC11428093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.